Impaired sensitivity to thyroid hormones encompasses disorders with defective transport of hormones into cells, reduced hormone metabolism, and resistance to hormone action. Mediated by heritable single-gene defects, these rare conditions exhibit different patterns of discordant thyroid function associated with multisystem phenotypes. In this context, challenges include ruling out other causes of biochemical discordance, making a diagnosis using clinical features together with the identification of pathogenic variants in causal genes, and managing these rare disorders with a limited evidence base. For each condition, the present guidelines aim to inform clinical practice by summarizing key clinical features and useful investigations, criteria for molecular genetic diagnosis, and pathways for management and therapy. Specific, key recommendations were developed by combining the best research evidence available with the knowledge and clinical experience of panel members, to achieve a consensus.

2024 European Thyroid Association Guidelines on diagnosis and management of genetic disorders of thyroid hormone transport, metabolism and action / L. Persani, P. Rodien, C. Moran, W. Edward Visser, S. Groeneweg, R. Peeters, S. Refetoff, M. Gurnell, P. Beck-Peccoz, K. Chatterjee. - In: EUROPEAN THYROID JOURNAL. - ISSN 2235-0640. - 13:4(2024 Aug 01), pp. 1-31. [10.1530/etj-24-0125]

2024 European Thyroid Association Guidelines on diagnosis and management of genetic disorders of thyroid hormone transport, metabolism and action

L. Persani
Primo
Writing – Original Draft Preparation
;
P. Beck-Peccoz
Penultimo
Membro del Collaboration Group
;
2024

Abstract

Impaired sensitivity to thyroid hormones encompasses disorders with defective transport of hormones into cells, reduced hormone metabolism, and resistance to hormone action. Mediated by heritable single-gene defects, these rare conditions exhibit different patterns of discordant thyroid function associated with multisystem phenotypes. In this context, challenges include ruling out other causes of biochemical discordance, making a diagnosis using clinical features together with the identification of pathogenic variants in causal genes, and managing these rare disorders with a limited evidence base. For each condition, the present guidelines aim to inform clinical practice by summarizing key clinical features and useful investigations, criteria for molecular genetic diagnosis, and pathways for management and therapy. Specific, key recommendations were developed by combining the best research evidence available with the knowledge and clinical experience of panel members, to achieve a consensus.
clinical practice guideline; deiodinase; diagnosis and management; impaired sensitivity to thyroid hormones; resistance to thyroid hormone; selenoprotein; thyroid hormone receptor; thyroid hormone transporter;
Settore MEDS-08/A - Endocrinologia
1-ago-2024
Article (author)
File in questo prodotto:
File Dimensione Formato  
2024 ETA guidelines on disorders of thyroid hormone transport, metabolism and action.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 4.98 MB
Formato Adobe PDF
4.98 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1105548
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 1
  • ???jsp.display-item.citation.isi??? ND
social impact